US FDA green flags to first post-partum depression pill.
Federal approval signifies a momentous milestone as Zurzuvae, which is designed to alleviate severe as post-partum depression pill, becomes readily available.
This treatment instills renewed hope in new mothers grappling with overwhelming emotions.